Related Experiment Video

Updated: Jul 29, 2026

An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

Drugs from the sea: a marine sponge-derived compound prevents Type 1 diabetes

L Van Kaer1

  • 1Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. vankael@ctrvax.vanderbilt.edu

Thescientificworldjournal
|June 14, 2003
PubMed

Insights

Type 1 diabetes, an autoimmune condition, affects over a million Americans, primarily children. It occurs when the body mistakenly attacks insulin-producing cells, necessitating lifelong insulin therapy.

Area of Science:

  • Immunology
  • Endocrinology
  • Pediatrics

Background:

  • Type 1 diabetes (T1D) is an autoimmune disease impacting over one million Americans.
  • It is characterized by the body's immune system destroying insulin-producing beta cells in the pancreas.
  • Nearly half of new T1D cases are diagnosed in children, with a diagnosis occurring every hour.

Purpose of the Study:

  • To elucidate the autoimmune mechanisms underlying Type 1 diabetes.
  • To highlight the lifelong implications of T1D, including insulin dependency and severe complications.
  • To underscore the urgent need for effective T1D treatments and cures.

Main Methods:

  • This study is a review of existing literature on Type 1 diabetes.
  • It synthesizes information on the pathophysiology, diagnosis, and complications of T1D.
  • The review focuses on the autoimmune destruction of pancreatic beta cells.

Main Results:

  • Type 1 diabetes results from the autoimmune destruction of pancreatic beta cells.
  • Insulin injections are required for survival but do not prevent long-term complications.
  • Complications include kidney failure, blindness, amputations, heart attack, and stroke.

Conclusions:

  • Type 1 diabetes is a serious autoimmune condition requiring lifelong management.
  • Current treatments manage blood sugar but do not offer a cure or prevent severe health issues.
  • Further research is crucial for developing curative therapies for T1D.

More Related Videos

Extraction and Analysis of Taiwanese Green Propolis06:50

Extraction and Analysis of Taiwanese Green Propolis

Published on: January 7, 2019

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...